ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,280 | -26.1% | 48,982 | +1.4% | 0.04% | -24.1% |
| Q2 2023 | $405,128 | -39.5% | 48,287 | -28.3% | 0.05% | -44.3% |
| Q1 2023 | $669,203 | +53.1% | 67,392 | +7.3% | 0.10% | +115.6% |
| Q4 2022 | $437,137 | +37.9% | 62,807 | +6.0% | 0.04% | -33.8% |
| Q3 2022 | $317,000 | +32.6% | 59,277 | -1.0% | 0.07% | +223.8% |
| Q2 2022 | $239,000 | -5.9% | 59,875 | +4.8% | 0.02% | -54.3% |
| Q1 2022 | $254,000 | +26.4% | 57,125 | +13.5% | 0.05% | +31.4% |
| Q4 2021 | $201,000 | -45.8% | 50,325 | +19.3% | 0.04% | -47.0% |
| Q3 2021 | $371,000 | +20.1% | 42,200 | +54.7% | 0.07% | +15.8% |
| Q2 2021 | $309,000 | +1.0% | 27,275 | -27.0% | 0.06% | +103.6% |
| Q1 2021 | $306,000 | +63.6% | 37,355 | +36.8% | 0.03% | -17.6% |
| Q4 2020 | $187,000 | – | 27,315 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |